Document is current

Article History

Received: 4 December 2024

Accepted: 13 June 2025

First Online: 3 July 2025

Declarations

:

: Institutional Review Board approval was not required because the test subjects were not subjected to an action, and no behavior was imposed on them, both as intended in the Dutch Medical Research Involving Human Subjects Act (WMO).

: The need to collect informed consent was waived because all of the following apply: (1) Explicit consent is impossible or can only be obtained with disproportionate efforts. (2) The research must serve a general (public health) interest. (3) The processing must be necessary for scientific or historical research or statistical purposes. (4) In the execution, safeguards must be provided to ensure that the patient’s personal privacy is not disproportionately affected. (5) The patient has not objected to the use of data.

: Authors S.S., A.K., R.K., S.T., S.Sat., R.A. and S.C. are full-time paid employees of Qure.ai. Author E.O.’s conflict of interest is: Research support and grant, General Electric Healthcare. Author J.V. conflicts of interest are the following: Grant to institution from Qure.ai, Enlitic; consulting fees from Tegus; payment to institution for lectures from Roche; travel grant from Qure.ai; participation on a data safety monitoring board or advisory board from Contextflow, Noaber Foundation, and NLC Ventures; leadership or fiduciary role on the steering committee of the PINPOINT Project (payment to institution from AstraZeneca) and RSNA Common Data Elements Steering Committee (unpaid); phantom shares in Contextflow and Quibim; member editorial board European Journal of Radiology (unpaid); chair scientific committee EuSoMII; chair ESR value-based radiology subcommittee. Authors H.R., J.P. and D.B. declare that they have no known competing interests.